I want to get a better understanding as to whether nvtr innovations differentiate it enough from competitors to overcome their competitor's sales relationships before I invest.
My understanding of Nuvectra's advantages are:
1. more effective lead placement
2. more effective in targeting 3 dermotomes instead of just 2
3. reduction in lead breakage and migration
4. more flexibility in programming different power settings to different areas
It would be great to get some feedback from doctors to confirm whether these are the important pain points and whether Nuvectra can address these pain points better than their competitors. Also, are there other pain points that trump the ones listed? Anyone know any neurosurgeons who specialize in this sort of thing?
Below is a link to an article about another new technology in SCS that is wireless which would likely negate the lead breakage and migration issue much more effectively than nvtr
http://www.businesswire.com/news/home/20141202005347/en/Stimwave-Receives-FDA-Clearance-World%E2%80%99s-Injectable-WirelessAlso, it looks like Nevro is suing Boston Scientific for infringing on its hf patent.
wjsco, thanks for doing the leg work on the patents. Also, thanks to stockspinoff for bringing the idea to the board.